Your browser is no longer supported. Please, upgrade your browser.
Settings
IMMU Immunomedics, Inc. daily Stock Chart
IMMU [NASD]
Immunomedics, Inc.
Index- P/E- EPS (ttm)-1.23 Insider Own7.49% Shs Outstand188.94M Perf Week1.80%
Market Cap3.42B Forward P/E- EPS next Y-1.00 Insider Trans0.00% Shs Float172.24M Perf Month1.29%
Income-219.30M PEG- EPS next Q-0.35 Inst Own79.70% Short Float16.51% Perf Quarter-15.27%
Sales1.50M P/S2278.62 EPS this Y-21.70% Inst Trans-0.06% Short Ratio11.00 Perf Half Y-29.58%
Book/sh1.84 P/B9.83 EPS next Y21.90% ROA-48.40% Target Price37.38 Perf Year13.13%
Cash/sh3.10 P/C5.84 EPS next 5Y- ROE-105.10% 52W Range12.86 - 27.33 Perf YTD26.77%
Dividend- P/FCF- EPS past 5Y-65.00% ROI-36.70% 52W High-51.21% Beta2.26
Dividend %- Quick Ratio- Sales past 5Y-15.40% Gross Margin62.90% 52W Low3.69% ATR1.28
Employees185 Current Ratio13.40 Sales Q/Q- Oper. Margin- RSI (14)34.47 Volatility4.78% 8.41%
OptionableYes Debt/Eq0.06 EPS Q/Q57.70% Profit Margin- Rel Volume13.54 Prev Close18.09
ShortableYes LT Debt/Eq0.06 EarningsFeb 06 AMC Payout- Avg Volume2.58M Price13.34
Recom1.60 SMA20-18.28% SMA50-26.94% SMA200-36.56% Volume28,845,002 Change-26.29%
Jan-18-19Downgrade Wells Fargo Outperform → Market Perform
Nov-08-18Resumed Jefferies Buy
Nov-05-18Initiated Morgan Stanley Overweight
Oct-19-18Initiated Piper Jaffray Overweight
Sep-17-18Initiated Goldman Buy $36
Jun-07-18Initiated B. Riley FBR, Inc. Buy $53
May-05-17Upgrade Wells Fargo Market Perform → Outperform
Oct-06-16Resumed Jefferies Buy
Jun-21-16Downgrade Wells Fargo Outperform → Market Perform
May-06-16Upgrade Jefferies Hold → Buy
Dec-04-15Downgrade Wells Fargo Outperform → Market Perform
Jul-29-15Downgrade Jefferies Buy → Hold
Aug-27-14Downgrade R. F. Lafferty Buy → Neutral $4
Jan-08-14Initiated Chardan Capital Markets Buy $9
Oct-02-13Reiterated Oppenheimer Outperform $6 → $8
Sep-10-13Initiated R. F. Lafferty Buy $8
Jun-03-13Initiated WallachBeth Buy $6
Aug-31-11Initiated Summer Street Research Buy $8
Jul-28-11Initiated Summer Street Research Buy $8
Jul-13-11Resumed Brean Murray Buy $8
Jan-18-19 01:49PM  Here's Why Immunomedics Plummeted on Friday Motley Fool -26.29%
01:45PM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Immunomedics, Inc. - IMMU ACCESSWIRE
12:44PM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline: February 25, 2019 ACCESSWIRE
12:15PM  INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
09:23AM  Block & Leviton LLP Reminds Shareholders of Securities Class Action Against Immunomedics; Investors Are Encouraged to Contact the Firm GlobeNewswire
07:49AM  The Daily Biotech Pulse: Regulatory Roadblock For Immunomedics, AdCom Split On Lexicon's Diabetes Drug Benzinga
06:41AM  Immunomedics Gets CRL From FDA for Breast Cancer Candidate Zacks
12:09AM  Immunomedics' cancer treatment fails to win accelerated approval from the FDA Reuters
Jan-17-19 08:36PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against NVIDIA, DXC Technology, Immunomedics, and Natural Health and Encourages Investors to Contact the Firm GlobeNewswire
08:30PM  Immunomedics' cancer treatment fails to win accelerated approval from the FDA Reuters
08:12PM  Immunomedics Receives Complete Response Letter From FDA for Sacituzumab Govitecan Biologics License Application GlobeNewswire
12:10PM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Jan-16-19 08:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immunomedics Inc. IMMU ACCESSWIRE
08:35PM  Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Immunomedics, Inc. (IMMU) Business Wire
03:01PM  IMMU $250K LOSS NOTICE: Rosen Law Firm Announces Securities Class Action Lawsuit Against Immunomedics, Inc.; Reminds Investors with Losses Over $250K of Important Deadline IMMU GlobeNewswire
02:25PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
12:42PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) & Lead Plaintiff Deadline: February 25, 2019 ACCESSWIRE
Jan-15-19 04:00PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of YOGA, YRCW, IMMU and YRIV GlobeNewswire
10:39AM  Kessler Topaz Meltzer & Check, LLP - Important Deadline Reminder for Immunomedics, Inc. Investors GlobeNewswire
Jan-14-19 04:40PM  CLASS ACTION UPDATE for YOGA and IMMU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
02:41PM  February 25th Immunomedics Shareholder Deadline: Bernstein Liebhard LLP Reminds Investors of the Important Upcoming Deadline in the Shareholder Class Action Lawsuit Against Immunomedics, Inc. IMMU GlobeNewswire
11:00AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) and Lead Plaintiff Deadline: February 25, 2019 GlobeNewswire
Jan-13-19 02:00PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of YOGA, IMMU and DXC GlobeNewswire
01:46PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immunomedics Inc. - IMMU ACCESSWIRE
Jan-12-19 12:01AM  Johnson Fistel, LLP Notifies Investors of Class Actions Against Sogou Inc., Immunomedics, Inc., and Ternium S.A.; Investors Encouraged to Contact Firm PR Newswire
Jan-11-19 10:50PM  IMMUNOMEDICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU GlobeNewswire
07:55PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immunomedics Inc. IMMU GlobeNewswire
05:35PM  IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
02:00PM  RM LAW Announces Class Action Lawsuit Against Immunomedics, Inc. PR Newswire
11:00AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of YOGA, IMMU and PRGO GlobeNewswire
Jan-10-19 07:17PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Aphria, NVIDIA, DXC Technology, and Immunomedics and Encourages Investors to Contact the Firm GlobeNewswire
05:25PM  Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Immunomedics, Inc. Business Wire
03:23PM  Signal Says Proceed With Caution on This Biotech Stock Schaeffer's Investment Research
01:57PM  CLASS ACTION UPDATE for YOGA and IMMU: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
12:10PM  SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:38AM  KESSLER TOPAZ MELTZER & CHECK, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Against IMMUNOMEDICS, INC. IMMU GlobeNewswire
09:47AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) and Lead Plaintiff Deadline: February 25, 2019 ACCESSWIRE
Jan-09-19 08:30PM  Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Immunomedics, Inc. Investors (IMMU) Business Wire
07:15PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immunomedics Inc. IMMU ACCESSWIRE
03:47PM  IMMU LOSS NOTICE: Rosen Law Firm Reminds Immunomedics, Inc. Investors of Deadline in Case Seeking to Recover Investor Losses IMMU Business Wire
12:30PM  SHAREHOLDER ALERT: YOGA IMMU NVDA: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
09:46AM  Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Immunomedics, Inc. Business Wire
08:30AM  INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
Jan-08-19 02:00PM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of YOGA, IMMU and NVDA GlobeNewswire +8.30%
01:50PM  SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Immunomedics, Inc. - IMMU ACCESSWIRE
01:35PM  Lawsuit for Investors in Shares of Immunomedics, Inc. (NASDAQ: IMMU) Announced by Shareholders Foundation ACCESSWIRE
10:46AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Immunomedics, Inc. (IMMU) and Lead Plaintiff Deadline: February 25, 2019 ACCESSWIRE
10:37AM  Investor Alert: Kaplan Fox Announces Investigation Of Immunomedics, Inc. PR Newswire
Jan-07-19 01:00PM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Immunomedics, Inc. (IMMU) and Lead Plaintiff Deadline: February 25, 2019 GlobeNewswire
12:26PM  SHAREHOLDER ALERT: YOGA IMMU NVDA DXC: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines GlobeNewswire
08:38AM  Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Immunomedics, Inc. - IMMU PR Newswire
Jan-05-19 09:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immunomedics Inc. IMMU GlobeNewswire
Jan-04-19 10:50PM  IMMUNOMEDICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU PR Newswire +5.32%
07:11PM  Robbins Arroyo LLP: Immunomedics, Inc. (IMMU) Misled Shareholders According to a Recently Filed Class Action Business Wire
04:02PM  Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Immunomedics, Inc. - IMMU GlobeNewswire
12:17PM  INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm GlobeNewswire
09:00AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Immunomedics, Inc. (IMMU) and Lead Plaintiff Deadline: February 25, 2019 ACCESSWIRE
07:30AM  Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Immunomedics, Inc. Investors Business Wire
Jan-03-19 09:30PM  Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Aphria, NVIDIA, DXC Technology, and Immunomedics and Encourages Investors to Contact the Firm GlobeNewswire
07:00PM  SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
02:27PM  Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Action Against Immunomedics, Inc. Business Wire
10:30AM  Glancy Prongay & Murray LLP Announces Investigation on Behalf of Immunomedics, Inc. Investors (IMMU) Business Wire
10:10AM  INVESTOR ALERT: Kaskela Law LLC Announces Investor Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm IMMU GlobeNewswire
Jan-02-19 06:57PM  INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation on Behalf of Immunomedics, Inc. Investors (IMMU) Business Wire
03:03PM  IMMUNOMEDICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics, Inc. - IMMU GlobeNewswire
02:58PM  INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
02:56PM  CLASS ACTION UPDATE for YOGA, IMMU and AGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
10:21AM  February 25th Immunomedics Shareholder Deadline: Bernstein Liebhard LLP Reminds Investors of the Important Upcoming Deadline in the Shareholder Class Action Lawsuit Against Immunomedics, Inc. IMMU GlobeNewswire
09:00AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Immunomedics, Inc. (IMMU) and Lead Plaintiff Deadline: February 25, 2019 ACCESSWIRE
Dec-31-18 02:21PM  INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Immunomedics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Dec-28-18 04:27PM  Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Immunomedics, Inc. (IMMU) and Encourages IMMU Investors to Contact the Firm GlobeNewswire
01:00PM  EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Immunomedics, Inc. Business Wire
10:51AM  SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Immunomedics, Inc. (IMMU) and Lead Plaintiff Deadline: February 25, 2019 GlobeNewswire
07:00AM  Immunomedics Class Action Lawsuit: Bernstein Liebhard LLP Announces That a Securities Class Action Lawsuit Has Been Filed Against Immunomedics, Inc. IMMU GlobeNewswire
Dec-27-18 07:12PM  Immunomedics Class Action Lawsuit: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Immunomedics, Inc. - IMMU PR Newswire -9.42%
06:06PM  Immunomedics Enters Into Supply Deal for Breast Cancer Drug Zacks
05:06PM  Block & Leviton LLP Files Securities Class Action Against Immunomedics, Inc. ("IMMU"); Investors Are Encouraged to Contact the Firm PR Newswire
Dec-26-18 08:00AM  Immunomedics and Johnson Matthey Announce Strategic Manufacturing Partnership GlobeNewswire +13.53%
Dec-24-18 08:39AM  Immunomedics (IMMU) in Focus: Stock Moves 6.1% Higher Zacks
Dec-21-18 06:10PM  Bragar Eagel & Squire, P.C. is Investigating Immunomedics, Inc. (IMMU) on Behalf of Stockholders and Encourages IMMU Investors to Contact the Firm GlobeNewswire +6.14%
03:30PM  IMMUNOMEDICS LOSSES ALERT: BERNSTEIN LIEBHARD LLP ANNOUNCES INVESTIGATION OF IMMUNOMEDICS, INC. - IMMU PR Newswire
01:23PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Immunomedics, Inc. GlobeNewswire
01:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immunomedics Inc. - IMMU ACCESSWIRE
12:38PM  Investor Alert Kehoe Law Firm, P.C. Investigating Potential Claims Against Certain Officers and Directors of Immunomedics, Inc. GlobeNewswire
10:00AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Immunomedics, Inc. (IMMU) GlobeNewswire
08:41AM  Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock? Zacks
Dec-20-18 07:32PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immunomedics Inc. - IMMU PR Newswire -19.67%
01:25PM  IMMUNOMEDICS, INC. (IMMU) Investigated For Violations of Federal Securities Laws by Block & Leviton LLP ACCESSWIRE
Dec-19-18 08:00AM  Immunomedics To Present at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-11-18 07:05AM  Today's Research Reports on Trending Tickers: Immunomedics and Amicus Therapeutics ACCESSWIRE
12:39AM  Hedge Funds Are Selling Immunomedics, Inc. (IMMU) Insider Monkey
Dec-06-18 08:03AM  Immunomedics Provides Clinical Updates on Breast Cancer Programs With Sacituzumab Govitecan GlobeNewswire
Dec-04-18 03:11PM  8 Companies That Could Disappear in 2019 InvestorPlace -8.60%
Dec-03-18 06:50PM  Cramer's lightning round: My playbook for Okta's earnings report CNBC
06:18PM  Edited Transcript of IMMU earnings conference call or presentation 7-Nov-18 10:00pm GMT Thomson Reuters StreetEvents
07:00AM  Today's Research Reports on Trending Tickers: Immunomedics and Amarin ACCESSWIRE
Nov-30-18 08:39AM  Why Immunomedics (IMMU) Could Be Positioned for a Slump Zacks +6.02%
Nov-27-18 08:55AM  New Research Coverage Highlights Immunomedics, Surmodics, PDF Solutions, Stepan, Express Scripts Holding, and BioCryst Pharmaceuticals Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Nov-19-18 08:35AM  Are Options Traders Betting on a Big Move in Immunomedics (IMMU) Stock? Zacks
Nov-08-18 04:09PM  Here's Why Immunomedics Fell as Much as 10.8% Today Motley Fool -9.16%
Immunomedics, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibody-based products for the targeted treatment of cancer. Its advanced antibody-drug conjugates are sacituzumab govitecan and labetuzumab govitecan, which are in advanced trials for various solid tumors and metastatic colorectal cancer, respectively. The company focuses on commercializing sacituzumab govitecan as a third-line therapy for patients with metastatic triple-negative breast cancer in the United States. The company also develops IMMU-140, a humanized antibody directed against an immune response target. Its other product candidates include products for the treatment of cancer and autoimmune diseases, including epratuzumab, an anti-CD22 antibody; veltuzumab, an anti-CD20 antibody; milatuzumab, an anti-CD74 antibody; and IMMU-114, a humanized anti-HLA-DR antibody. Immunomedics, Inc. has clinical collaboration with AstraZeneca and MedImmune, to evaluate Imfinzi, a human monoclonal antibody against PD-L1, with sacituzumab govitecan as a frontline treatment of patients with TNBC and urothelial cancer; collaboration agreement with The Bayer Group for the development of epratuzumab; clinical and preclinical collaborations with academic cancer institutions, identifying new cancer indications for sacituzumab govitecan and the biology of the Trop-2 antigen; and research collaboration with the Memorial Sloan Kettering Cancer Center to investigate Sacituzumab Govitecan and Labetuzumab Govitecan in preclinical cancer models. Immunomedics, Inc. has a partnership agreement with the Samsung BioLogics Co., Ltd. to manufacture hRS7, an Immunomedics proprietary humanized antibody. The company was founded in 1982 and is headquartered in Morris Plains, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
venBio Select Advisor LLCDirectorJun 15Buy24.00575,00013,800,00017,514,461Jun 15 02:02 PM
venBio Select Advisor LLCDirectorJun 15Buy23.39200,0004,678,00017,714,461Jun 19 04:05 PM
GOLDENBERG DAVID MDirectorMar 07Sale17.6840,000707,0005,613,252Mar 12 08:32 PM
GOLDENBERG DAVID MDirectorMar 07Sale17.5020,000350,0001,774,285Mar 12 08:32 PM
GOLDENBERG DAVID MDirectorMar 05Sale17.2440,000689,4005,653,252Mar 12 08:32 PM
GOLDENBERG DAVID MDirectorFeb 28Sale17.0917,729302,9895,693,252Mar 12 08:32 PM